Valuation: Mesa Laboratories, Inc.

Market Cap 723M 649M 599M 544M 1.02B 68.7B 1.03B 7.19B 2.85B 36.01B 2.71B 2.66B 114B P/E 2027 *
60.8x
P/E 2028 * 46.6x
Enterprise Value 723M 649M 599M 544M 1.02B 68.7B 1.03B 7.19B 2.85B 36.01B 2.71B 2.66B 114B EV / Sales 2027 *
2.84x
EV / Sales 2028 * 2.67x
Free-Float
94.38%
Yield 2027 *
0.5%
Yield 2028 * 0.5%
1 day-0.48%
1 week+3.27%
Current month-0.53%
1 month-3.57%
3 months+32.20%
6 months+31.51%
Current year+64.65%
1 week 124.95
Extreme 124.95
133.41
1 month 122.23
Extreme 122.23
144.35
Current year 71.06
Extreme 71.065
144.35
1 year 69.51
Extreme 69.51
144.35
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 56 12/04/2026
Director of Finance/CFO 58 29/10/2012
Comptroller/Controller/Auditor 41 01/01/2022
Director TitleAgeSince
Chairman 73 01/09/2017
Director/Board Member 58 04/03/2019
Director/Board Member 57 11/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/26 Free

Director

2,510 0.0449%
9/9/26 Free

Director

2,423 0.0433%
9/9/26 Free

Director

1,774 0.0317%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%+3.27%+68.11%+33.91% 723M
-1.70%+0.63%-18.93%+11.04% 178B
-1.54%-0.98%-21.45%+15.09% 116B
-0.89%-0.72%-0.19%+35.32% 115B
-0.11%+4.46%-42.82%+7.89% 93.1B
-1.40%-5.21%-3.18%+73.40% 62.09B
+0.17%-0.34%+10.87%+84.40% 55.87B
-0.69%+0.63%+4.27%-22.48% 53.12B
-1.57%+0.60%-13.31%+43.41% 44.22B
-0.83%+2.43%-3.67%-9.31% 33.59B
Average -0.63%+2.37%-2.03%+27.26% 75.17B
Weighted average by Cap. -0.41%+2.37%-13.16%+24.24%

Financials

2027 *2028 *
Net sales 254M 228M 211M 191M 357M 24.17B 362M 2.53B 1B 12.67B 955M 935M 40.17B 271M 243M 224M 204M 380M 25.73B 385M 2.69B 1.07B 13.48B 1.02B 995M 42.76B
Net income 12.7M 11.4M 10.52M 9.54M 17.84M 1.21B 18.06M 126M 50.11M 632M 47.67M 46.65M 2.01B 17.35M 15.57M 14.38M 13.04M 24.37M 1.65B 24.67M 172M 68.46M 864M 65.13M 63.73M 2.74B
Net Debt - -
Projected Income Statement - Annual - Mesa Laboratories, Inc.
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
27/10/26 US$129.25 -0.48% 90,091
26/10/26 US$129.87 +0.94% 52,472
23/10/26 US$128.66 -0.34% 88,259
22/10/26 US$129.10 -0.08% 77,460
21/10/26 US$129.20 +3.23% 84,175
Trader
-
Investor
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Mesa Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
129.25USD
Average target price
125.00USD
Spread / Average Target
-3.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mesa Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. MLAB Stock